RecruitingChin Augmentation
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
Eligible age
22+ yrs
Accepts
All genders
Locations
6 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.
Sponsor: Galderma R&D
You may qualify if…
- ✓ 1. Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
- ✓ 2. Intent to receive treatment for augmentation and correction of retrusion in the chin region.
You may not qualify if…
- ✕ 1. Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins.
- ✕ 2. Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics.
- ✕ 3. Previous or present multiple allergies or severe allergies, such as manifested by anaphylaxis or angioedema, or family history of these conditions.
- ✕ 4. Previous facial surgery (including facial aesthetic surgery and liposuction), below the level of the horizontal line from subnasale.
- ✕ 5. Any previous aesthetic procedures or implants.
- ✕ 6. Presence of any disease or lesions near or on the area to be treated.
Where it's recruiting
Source: ClinicalTrials.gov · NCT07566286 · last updated 2026-08-14